173 related articles for article (PubMed ID: 36249772)
1. Pharmacists' experiences on adverse drug reaction: 10 years later.
Karuppannan M; Mohamad Rizal NAN; Wong KT; Mohd Ali S; Ting KN; Boardman H
Front Pharmacol; 2022; 13():932942. PubMed ID: 36249772
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
4. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Adverse Drug Reaction Reporting in Ethiopia.
Anbeo ZG; Abacıoğlu N
Turk J Pharm Sci; 2023 Jul; 20(3):198-209. PubMed ID: 37417202
[TBL] [Abstract][Full Text] [Related]
6. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
Sweis D; Wong IC
Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
[TBL] [Abstract][Full Text] [Related]
7. Exploring Healthcare Professionals' Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions.
Srisuriyachanchai W; Cox AR; Jarernsiripornkul N
Healthcare (Basel); 2022 Jun; 10(6):. PubMed ID: 35742128
[TBL] [Abstract][Full Text] [Related]
8. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
Hussain R; Hassali MA; Hashmi F; Akram T
J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
[TBL] [Abstract][Full Text] [Related]
9. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework.
Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
Interact J Med Res; 2022 Oct; 11(2):e40597. PubMed ID: 36222800
[TBL] [Abstract][Full Text] [Related]
10. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
11. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
Danekhu K; Shrestha S; Aryal S; Shankar PR
Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
[No Abstract] [Full Text] [Related]
12. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria.
Adegbuyi TA; Fadare JO; Araromi EJ; Sijuade AO; Bankole I; Fasuba IK; Alabi RA
Hosp Pharm; 2021 Dec; 56(6):751-759. PubMed ID: 34732934
[TBL] [Abstract][Full Text] [Related]
15. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
16. Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals' Perspectives on How to Improve Reporting.
Sandberg A; Salminen V; Heinonen S; Sivén M
Healthcare (Basel); 2022 May; 10(6):. PubMed ID: 35742066
[TBL] [Abstract][Full Text] [Related]
17. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.
Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR
Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting by community pharmacists in the Greater Accra Region of Ghana, 2016.
Osei JY; Nortey PA; Bandoh DA; Kenu E; Addo-Lartey AA
Ghana Med J; 2021 Mar; 55(1):9-17. PubMed ID: 38322393
[TBL] [Abstract][Full Text] [Related]
19. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
de Vries ST; Denig P; Andrić A; Dimov Di Giusti M; Ptaszynska-Neophytou A; Härmark L; Mol PGM;
Drug Saf; 2021 Oct; 44(10):1073-1083. PubMed ID: 34368940
[TBL] [Abstract][Full Text] [Related]
20. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
Barnes J; Butler R
Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
